A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT03551522 · TERMINATED
Trial details
- NCT number
- NCT03551522
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-30
- Primary completion
- 2019-05-08
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.